DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

Sanofi (ADR) (NYSE: SNY)



company name or ticker
Company Photos
(Click to zoom)

MannKind Enters into a Global Deal with Sanofi for Afrezza - Analyst Blog

Synta Pharmaceuticals: The Data Justify A Much Higher Share Price

Closing Update: Stocks Firm, Pare Gains as NATO Questions Russian Aid Overtures to Revive Geopolitic

Closing Update: Stocks Firm, Pare Gains as NATO Questions Russian Aid Overtures to Revive Geopolitical Concern

Update: Merrimack Earnings - Looming Concerns Still Remain

Why MannKind Corporation Stock Briefly Soared

MannKind stock is birefly a big gainer after announcing a long-awaited licensing deal for its lead drug, Afrezza. Find out what this means for shareholders.

Sector Update: Health Care Stocks Log Narrow Advance; MannKind Inks Pact for Inhaled Insulin

Jim Cramer's Mad Dash: Good News for Tesla and MannKind

MannKind Secures Future of Afrezza in Major Sanofi Deal

Why ManKind (MNKD) Stock Is Soaring Today

US Stock Futures Signal Higher Start On Wall Street

See More Articles...